Dr.Reddys Laboratories reported INR86.98B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Bharat Petroleum INR 1.49T 19.2B Sep/2026
Cipla INR 74.04B 2.85B Sep/2026
Dr.Reddys Laboratories INR 86.98B 6.27B Sep/2026
Sun Pharmaceuticals INR 161.99B 8.99B Sep/2026
UPL INR 118.6B 16.79B Sep/2026